News Briefing channel feed – Endpoints News

News Briefing channel feed

Iovance's $211M offering; Almirall licenses Novo drug; AstraZeneca files Dato-DXd; Sonata layoffs

Last year

XOMA to buy Kinnate; A pain biotech’s small IPO

Last year

KalVista wants to raise $160M; Prime Medicine's upsized offering; Applied Tx's PhIII data

Last year

Merrimack to dissolve after recording $225M milestone; Cogent's $225M placement

Last year

BMS, VantAI team up; CRISPR Therapeutics to raise $280M; Ono Pharma's deal with Shattuck Labs

Last year

Immunovant's plans for autoimmune asset; Wall Street worries about Moderna’s RSV candidate

Last year

Vicore sells rights to IPF drug in Japan; Roche to lay off 340 workers; Sensorion’s €50M offering

Last year

Lilly picks a Foghorn target; Mineralys’ $120M PIPE; Sana's $165M offering

Last year

Jazz's KRAS deal with Redx; Alto Neuroscience upsizes IPO

Last year

Immunome buys desmoid tumor asset; UK looks into Thermo Fisher-Olink deal; Kyverna's upsized IPO

Last year

Novartis reportedly in talks to buy MorphoSys; Astellas cuts PhII program; Silence's $120M private placement

Last year

Hutchmed's licensing deal, worth up to $227M; Tyra's $200 PIPE

Last year

Basking raises $55M; Seroba’s fourth fund; Vera upsizes its public offering

Last year

Halia's $30M Series C; Windtree assesses 'strategic' options; LifeArc, Gates invest in Africa accelerator

Last year

Kura’s stock jumps on PhIb readout; FDA lifts hold on INmune Bio program; Nanobiotix’s $20M milestone

Last year

Ascendis spins out ophthalmology company; Gamida Cell eyes strategic options

Last year

Deerfield gives up rights to Windtree therapy; Travere inks deal with Renalys in Asia; Celularity raises $21M

Last year

Glenmark, Alphamab deal worth up to $700M; Tourmaline’s $150M offering; Repare records $40M milestone

Last year

Kura’s $150M PIPE; Lilly’s investment in Prism BioLab; Annovis delays PhIII data, citing ‘data cleaning’

Last year

Merck inks deal with Unnatural Products; CG Oncology’s upsized IPO; Locus gets $24M from BARDA

Last year

Sagimet’s positive PhIIb NASH data; FDA lifts hold on Pharvaris IND; Dianthus raises $230M

Last year

PMV to cut 30% of its workforce; Edgewise, Esperion announce public offerings

Last year

Viridian’s $150M offering; Surrozen scraps IBD drug candidate; Assembly ends deal with Indiana University

Last year

Lee’s Pharma to develop Windtree drug in China; Acurx shares PhIIb antibiotic data; Granata raises $14M

Last year

First page Previous page 10 11 121314 15 16 Next page Last page